04/25/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
6:33 AM | Candel Therapeutics (Filer)
| Form 10-K/A | |
04/11/2024
8:00 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
7:00 AM | Candel Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
7:16 AM | Candel Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
03/28/2024
6:45 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
7:00 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
8:00 AM | Candel Therapeutics (Filer)
| Form 424B5 | |
02/13/2024
6:45 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
7:30 AM | Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/12/2024
3:30 PM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
4:00 PM | Amello Jason (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
4:00 PM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
4:00 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
4:00 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
4:00 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
8:00 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:16 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:31 AM | Candel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
7:53 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
10:31 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
7:31 AM | Candel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
8:00 AM | Candel Therapeutics (Issuer)
Nabel Gary J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:00 AM | Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:00 AM | Candel Therapeutics (Issuer)
PAPA JOSEPH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:00 AM | Benz Edward J. JR (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:00 AM | Candel Therapeutics (Issuer)
Martell Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:00 AM | Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:00 AM | Candel Therapeutics (Issuer)
Nguyen Diem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:00 AM | Candel Therapeutics (Issuer)
Gaeta Renee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
7:31 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
7:31 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2023
7:45 AM | Candel Therapeutics (Issuer)
Loggia Nicoletta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
7:30 AM | Candel Therapeutics (Issuer)
Loggia Nicoletta (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad) See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space. Click to read |
06/08/2023
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
7:00 AM | Candel Therapeutics (Filer)
| Form DEF 14A | |
05/23/2023
7:01 AM | Candel Therapeutics (Filer)
| Form ARS | |
05/19/2023
8:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
7:46 AM | Candel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023
7:31 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
